Evidence map›Paper›PMID 28677263›Full record

Trial reportBritish journal of clinical pharmacology2017

Does a glass of Coke boost the exposure to imatinib in gastrointestinal stromal tumour patients after gastrectomy?

Floor J E Lubberman, Hans Gelderblom, Carli M Wilmer, Dina M Kweekel, Ingrid M E Desar, Angela Colbers, David Burger, Winette T A van der Graaf, Nielka van Erp

Registry-linked trialAbstract readLetterRandomized Controlled Trial
In one paragraph

Trial report in British journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02185937 (Influence of an Acidic Beverage), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02185937 phase1terminatednot on this map

Influence of an Acidic Beverage (Coca-Cola) on the Exposure to Imatinib (GLIvec) After Major gastrecTomY in Patients With Gastrointestinal Stromal Tumors (ABILITY)

TypeinterventionalSponsorRadboud University Medical CenterRan2014 to 2016Enrolled5ConditionsGastrointestinal Stromal Tumor, Major GastrectomyArmscola
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Floor J E LubbermanDepartment of Pharmacy and Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-5537-0784
Hans GelderblomDepartment of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Carli M WilmerDepartment of Pharmacy and Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Dina M KweekelDepartment of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Ingrid M E DesarDepartment of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Angela ColbersDepartment of Pharmacy and Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
David BurgerDepartment of Pharmacy and Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Winette T A van der GraafDepartment of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Nielka van ErpDepartment of Pharmacy and Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carbonated BeveragesAntineoplastic AgentsCross-Over StudiesFood-Drug InteractionsGastrectomyGastrointestinal NeoplasmsGastrointestinal Stromal TumorsHumansImatinib MesylateAntineoplastic AgentsImatinib Mesylateacidic beverageimatinibmajor gastrectomypharmacokinetics

Identifiers

PMID28677263
PMCPMC5595978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.